86.22.Z - Specialist medical practice
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
58.19.Z - Other publishing activities, excluding software publishing
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,5 | -0,7 | -0,5 | 35 |
Gross profit (loss) | 0,5 | 0,1 | 0,5 | 509,5 |
EBITDA | 0,6 | 0,1 | 0,6 | 361,7 |
Short time liabilities | 0,2 | 0,3 | 0,3 | 12,3 |
Other operating costs | 0 | 0 | 0 | 152,3 |
Equity capital | 4,2 | 4,2 | 4,7 | 11,1 |
Operating profit (EBIT) | 0,5 | 0,1 | 0,5 | 705,4 |
Assets | 4,3 | 4,5 | 5 | 11,2 |
Net profit (loss) | 0,5 | 0,1 | 0,5 | 614 |
Cash | 1,9 | 1,9 | 2,1 | 6,1 |
Net income from sale | 4,4 | 5,5 | 6,3 | 13,2 |
Liabilities and provisions for liabilities | 0,2 | 0,3 | 0,3 | 12,3 |
Working assets | 2 | 2,3 | 2,7 | 14,9 |
Other income costs | 1 | 0,8 | 1 | 26,8 |
Depreciation | 0,1 | 0,1 | 0,1 | 32,8 |
% | % | % | p.p. | |
Profitability of capital | 12,7 | 1,6 | 10 | 8,4 |
Equity capital to total assets | 96,5 | 93,3 | 93,2 | -0,1 |
Gross profit margin | 12,1 | 1,5 | 7,9 | 6,4 |
EBITDA Margin | 13,8 | 2,3 | 9,2 | 6,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 13 | 20 | 20 | 0 |
Current financial liquidity indicator | 13.249550819396973 | 7.6457839012146 | 7.823976993560791 | 0,2 |
Net dept to EBITDA | -3.198774814605713 | -15.5790376663208 | -3.5810940265655518 | 12 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane